Supplementary Figure 7 from ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer

Key Points

• The study reveals significant allelic imbalance in oncogenic mutations in circulating tumor DNA from metastatic urothelial cancer.
• Mutations were detected in ctDNA samples, indicating their potential role in tracking tumor dynamics and progression.
• This analysis of metastatic urothelial cancer highlights important genetic changes associated with the disease.
• Findings emphasize the relevance of ctDNA for understanding tumor heterogeneity in metastatic urothelial cancer patients.